HBI Deals+Insights / M&A/IPOs
Private equity firm Nordic Capital-backed LEO Pharma, a provider of medical dermatology solutions, has acquired gene therapy company Replay, which develops gene therapies for rare genetic conditions
Replay’s equity holders will receive $50 million upfront, with additional milestone payments and tiered single-digit royalties.





